PBS listing – Ferro-Tabs

AFT Pharmaceuticals is pleased to announce that from 01 September 2011 it’s iron replacement product Ferro-Tabs will be PBS Listed.

“This will make iron replacement therapy more readily available for groups in need such as indigenous peoples or the elderly and will assist in the implementation of the recommendations made by the National Iron Deficiency Anaemia expert groups,” said Group CEO, Dr Hartley Atkinson.

May 26, 2025

AFT and Hikma extend US Maxigesic Cooperation

AFT Pharmaceuticals (NZX:AFT, ASX:AFP) today announces it has extended its US Maxigesic® licensing agreement with Hikma Pharmaceuticals….

Read More

May 1, 2024

AFT Licenses Maxigesic® IV in Brazil

We are delighted to announce our partnership with Brazil’s Halex Istar, and to be exclusively responsible for distributing its Maxigesic IV in Brazi…

Read More

April 24, 2024

AFT, Massey Ventures, Gilles McIndoe to develop scar treatment

AFT collaborate with Massey Ventures and Gilles McIndoe to begin the development of a topical treatment for keloid and hypertrophic scarring….

Read More